Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • Drew Meredith

  • Ishan Dan

  • Staff Writer

  • The Inside Adviser

Tesla among six new stocks added to the Chi-x TraCRs platform

Investors are piling into COVID-hit international companies amid a share trading boom. According to ASIC’s analysis of trading volumes during the COVID period, share trading volumes among retail investors have doubled. With that in mind, international share trading has become a lot easier, but can still come at a substantial cost, with added tax implications,…

Ishan Dan | 2nd Nov 2020 | More
Getting to know Angela Ashton

This week we spoke with Angela Ashton, founder of Evergreen Consulting, who recently launched her Investment Research business. Angela, can you tell us a little about yourself; what has been your favourite weekend activity in COVID-19 lockdown? Watching Netflix, walking, and drinking rosé. And your favourite holiday destination pre-COVID 19?Too many – I love New…

The Inside Adviser | 22nd Oct 2020 | More
Opportunity amidst the pandemic

As much as the industry is improving its professionalism, financial advice remains “cottage.” There are many providers, in many forms, located all across the country. This trend is only accelerating as the major banks and financial institutions finalise their exits from the industry. We all do business and deliver advice in different ways with very…

The Inside Adviser | 12th Oct 2020 | More
  • Q&A with Fabio Ferro

    This week we had the pleasure of speaking with the exceptional Fabio Ferro, Director of Scala Private Wealth. Specialising in investment advice for high-net-worth families, Fabio is an avid writer and outspoken market commentator. Here’s what he had to say: Favourite weekend activity in COVID-19 lockdown? Heading out cycling with my boys. What was your…

    Staff Writer | 5th Oct 2020 | More
    ASX update; COVID-19 impacting Macquarie Group

    Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…

    Drew Meredith | 14th Sep 2020 | More
    Market update – Federal Reserve loosens inflation reins

    It was a mixed day for the market, the ASX 200 (ASX:XJO) finished 0.2% higher despite trading up as much as 0.8% during the day.

    Drew Meredith | 27th Aug 2020 | More